Tags: Drug.

Lanreotide (INN) is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors most notably carcinoid syndrome. It is a long-acting analogue of somatostatin like octreotide.Lanreotide (as lanreotide acetate) is manufactured by Ipsen and marketed under the trade name Somatuline.

Lanreotide.svg
ATC prefix
H01
ATC suffix
CB03
CAS number
108736-35-2
FDA UNII code
0G3DE8943Y
IUPAC name
(2R)-2-amino-3-naphthalen-2-yl-propanoyl]amino]-N-[(1S2R)-1-carbamoyl-2-hydroxy-propyl]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-69121518-pentaoxo-7-propan-2-yl-12-dithia-58111417-pentazacycloicosane-4-carboxamide, (4S7S10S13R16S19S)-10-(4-aminobutyl)-19-
PubChem
71349

Loading...

This page contains content from the copyrighted Wikipedia article "Lanreotide"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.